Catalyst Pharmaceutical Partners Inc. (CPRX) was a big mover last session, as its shares rose nearly 9% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since March 20, as the stock is trading above the volatile price range of $2.21 to $2.39.
In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.
Catalyst Pharmaceutical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other well-performing stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. (WX), IntelliPharmaCeutics International (IPCI) and Cardiome Pharma Corp. (CRME). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CATALYST PHARMACEUTICAL PARTNERS (CPRX): Free Stock Analysis Report
INTELLIPHARMACEUTICS INTERNATION (IPCI): Free Stock Analysis Report
WUXI PHARMATECH CAYMAN INC (WX): Free Stock Analysis Report
CARDIOME PHARMA CORP ORD (CRME): Free Stock Analysis Report
Zacks Investment Research